ReviewChemistry & biodiversity2026
Reviewing Marine Bioactive Compounds From the Red Sea: Advancing Therapeutic Applications While Navigating Translational and Conservation Challenges.
Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Chemistry and Pharmacology of the Alkaloid Barettin and Its Analogues from the Marine SpongeMarine drugs · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Red Sea, a biologically rich marine ecosystem, is a promising source of novel bioactive compounds with significant therapeutic potential. This review analyzes a decade of research on the isolation, characterization, and biological activities of compounds obtained from sponges, corals, microalgae, seaweeds, marine fish, and microorganisms. These bioactive molecules, including alkaloids, glycosides, terpenes, and peptides, exhibit antimicrobial, anticancer, anti-inflammatory, and neuroprotective properties. Various extraction techniques, ranging from traditional solvent extraction to advanced methods such as supercritical fluid and ultrasound-assisted extraction, aid in their isolation. Meanwhile, chromatographic purification and bioassay-guided fractionation enhance their identification. However, challenges such as limited availability, complex extraction processes, and regulatory constraints hinder the clinical translation of these technologies. Addressing these barriers requires innovative extraction strategies, advanced characterization techniques, and interdisciplinary approaches that integrate marine biology with emerging technologies, such as deep learning. Future research should focus on exploring molecular interactions within coral reef ecosystems, unraveling marine bacterial diversity, and implementing conservation strategies to protect the Red Sea's unique biodiversity while accelerating drug discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.